top of page
Nelson Advisors >
European HealthTech & MedTech
!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.
Homepage
Meet Nelson Advisors
lloyd@nelsonadvisors.co.uk
Samsung-Verily Partnership: Strategic Integration of Wearable Biometrics and AI Native Precision Health Platforms
Acquisition Framework for Anthropic and the Claude Ecosystem: Strategic Consolidation of Healthcare AI
Structural Convergence in Behavioural Healthcare: A Comprehensive Analysis of the Universal Health Services Acquisition of Talkspace
The Strategic Evolution of Patient Engagement in the NHS: The Post Wayfinder Era and Consolidation of the 'Digital Front Door'
Strategic Analysis of the HealthTech and MedTech Ecosystem on the FTSE AIM
The Advent of Vibe Coding in Healthcare: Orchestrating the Future of Medical Software Development
This Week in European MedTech and HealthTech: 6th March 2026
The Evolution of Agentic Clinical Ecosystems: Analysis of Amazon Connect Health
Oura's Double Point Acquisition Analysis: Ambient Bio-Sensing and Healthcare 2030
Strategic Consolidation of Digital Nutrition: Analysis of the MyFitnessPal Acquisition of Cal AI
Do we have a Dunning Kruger effect problem in healthcare AI?
The Exit Factor: Why M&A is on the rise in HealthTech - Nelson Advisors HLTH Europe 2026
Healthcare AI’s evolution from the "Scribe Wars" toward the "Clinician AI stack"
The Strategic Consolidation of Patient Engagement: Assessing the Viability of the Third Party Portal Market Amidst the Expansion of the NHS App
HealthTech HALO Effect: Heavy Assets, Low Obsolescence in the Healthcare AI Era
The Convergence of Clinical Intelligence and Patient Outreach: Analysis of OpenEvidence’s AI Integrated Telehealth Ecosystem
Strategic Realignment of European AI Governance: Analysis of AI Omnibus Proposal and Impact on EU AI Act
This Week in European MedTech and HealthTech: 27th February 2026
Healthcare Business International interviews Nelson Advisors discussing the Hims & Hers acquisition of Eucalyptus
How could the Software sell off and AI bubble in early 2026 affect Digital Health, HealthTech and MedTech funding and M&A for the rest of 2026?
The Strategic Evolution of European Healthcare Investment Banking: A Definitive Analysis of Nelson Advisors and the Specialised Boutique Ascendancy
FemTech's transition from fragmented Venture Capital category into Women’s Health and pillar of Global Healthcare Acquisition strategies
The 2026 Biopharmaceutical M&A Renaissance: Strategic Consolidation Amidst Patent Volatility and Technological Convergence
Every Cure and Computational Pharmacophenomics: A New Field of Medicine
Nelson Advisors
bottom of page
